AXP 0.00% 0.2¢ axp energy limited

It's that time of year with Au market packing up and heading to...

  1. 5,445 Posts.
    lightbulb Created with Sketch. 160
    It's that time of year with Au market packing up and heading to the beach that good news won't lift much as simply funds ( not that they are in here anyway) sit on cash and await the sheep group mentality in January and always get 50% plus of their quarters return just because of weight of $ returning. Gotta wonder if people know teh numbers as I am not sure what the lead time and real annual  cycle is on need for them and if they are getting more in teh market to use em. The insidersfrom hospital admins know   and the stats firms follow all procedure numbers getting direct from hospitals before formal reporting.  Tough game. Honestly would have to be stunning numbers to stop the gradual drift on no news and actually get a rise.  Structure doesn't look an easy one for anyone to buy em out so it will be a hard road IMO.   15 mill market cap is crazy but then you look at accounts, structure and just shake head when combined with history.   Someone in the industry with medium term outlook could do very well with a controlling interest and ensuring right management and strategy is put in place with internal finance but then they would probably just milk it untill frustrated retail holders give it up at a low valuation.



    . Have been looking at a  v  H - recell as well and it has plenty of cash now and a huge overhang of shares just raised and only way out for them is good numbers in jan - June period next year and the possible excitement of trying to partial  list in USA but with the snouts in the trough  it will take a smart small holder to do well with limited patent and protection coverage so only 6 years to make the $.Their approved market is limited and unless offlable takes off there won't be the needed volume at the pricepoint  IMO.  Now controlled by 2  funds who will paly with it as required.   Should be a no lose position with product approved but a tough gig for single product company who need further expensive and timely trials to get more products out there.    Shame such great ideas in biotech in Australia are managed so poorly and yet we have runners  running pumped to silly valuations on no serious science. Those runners are absorbing the interest and $ from better long term prospects and burning small retail is my guess. R  h  T  is the latest pump and I hope the long term holders take advantage of the liquidity and pricing and don't become bagholders as they have a tough slow road even as the gold standard simply as drug makers use them for trials and practicioners currently avoid using MRI in real world due to cost and accessibility where other options exist and surgeons are slow to change. Repackaging cheaper down the cost curve using AI for analysis doesn't overcome the actual cost of MRI required. Still great idea and quality but seems related party arrangements seem to make the $ not the listed vehicle.   At different time of year I'm sure they would have taken teh opportunity to use other peoples $ and raise $ but timing has stuffed em I think.


    POOOH  well the dreamers still believe they have the mother lode and can pick up the end of pooh and not get dirty fingers. While management are doing their best to stay employed - see what they come up with but with no cash and settlement for costs from lost arbitration they are in the Pooooh  They'll be sweating this morning and the crew that has sucked so many in over the years will keep playing for pips for all the emotionally involved using every cliche ever invented and subtle ramps as for years they have got away with it and so many nics teh mind boggles..


    Factor - a shell with management milking it till they can get roles elsewhere by the look of it after trial failure.   The ol' single trial and seemingly didn't do enough number processing and a new confirmatory p11 to check dodgy priors with now better SOC  and placebo defeating a  low powered trial with high hurdle.   Not good look for the ol' au biotech and very expensive to retail.


    Will microcaps and small caps be flavour of the month in 2019 and will bio after a terrible end to the year be serious players in that space or just fodder for the pumping crews?


    Have a great break everyone.


    Last edited by Teddyward: 1071 14/12/18
 
watchlist Created with Sketch. Add AXP (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $5.824M
Open High Low Value Volume
0.2¢ 0.2¢ 0.1¢ $1.352K 801.6K

Buyers (Bids)

No. Vol. Price($)
32 43009120 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 94329583 62
View Market Depth
Last trade - 14.27pm 29/11/2024 (20 minute delay) ?
AXP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.